Multiplikator Forward P/S: IceCure Medical Ltd. (ICCM)
Sales of advanced ProSense systems are driving the current growth of IceCure Medical Ltd (ICCM). The application of minimally invasive cryoablation methods reduces waste, supporting the principles of sustainable healthcare. The forward P/S history demonstrates valuation dynamics, where the value has stabilized at 0.60. However, risks are associated with slow technology adoption by physicians, dependence on insurance reimbursements, and the need for FDA approval.
Ringkesan rincian data analitis icecure-medical.com (ICCM)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal IceCure Medical Ltd|ICCM - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal IceCure Medical|ICCM - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku IceCure Medical Ltd|ICCM - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan IceCure Medical|Rasio cepet icecure-medical.com
- rincian asil keuangan lan kelipatan valuasi:
ICCM - Penghasilan resik perusahaan|Bathi sing dikarepake IceCure Medical Ltd|ICCM - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi IceCure Medical|ICCM - Pangali PEG|Pangali EV/EBITDA IceCure Medical Ltd|ICCM - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan IceCure Medical|ICCM - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan icecure-medical.com|ICCM - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep IceCure Medical Ltd
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:ICCM (IceCure Medical, Ltd.)
To protect portfolio capital, priority is given to assets with predictable revenue growth, which for IceCure Medical Ltd (ICCM) is driven by high operating leverage from the sale of disposable cryoprobes. The trend of the future P/S metric reflects the market valuation of expected sales volume relative to market capitalization, allowing investors to determine the extent of future income compression under the influence of inflationary pressure and operating expenses.
Karo sapa IceCure Medical Ltd saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (SANUWAVE Health, Inc.) - Multiplikator forward rega marang pendapatan|Outset Medical Corp - Rega forward marang dodolan|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep lensar.com LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical (RCEL)|profoundmedical.com (PROF) - Prakiraan rega marang pendapatan|Baird Medical - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP TMS SA EDAP|Bovie Medical - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Pulmonx Corporation LUNG|telabio.com (TELA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CTSO (CytoSorbents Corporation)|Rasio rega marang prakiraan pendapatan Sensus Healthcare Corp|Multiplikator forward rega marang pendapatan Zynex Corp (ZYXI)|Multiplikator Forward P/S ECOR|RBOT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Inspira Technologies IINN|ICU: Kapitalisasi marang prakiraan pendapatan|IRIX: Multiplikator forward rega marang pendapatan|Intelligent Bio Solutions - Rasio rega marang pendapatan sing dikarepake|XAIR: Multiplikator Forward P/S|PFSA - Rasio kapitalisasi marang dodolan sing dikarepake|SSKN (STRATA Skin Sciences Inc.) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan glucotrack.com (GCTK)|Multiplikator Forward P/S NAOV|VERO - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S NUWE (Nuwellis, Inc.)|AEMD - Multiplikator forward rega marang pendapatan|ASXC: Multiplikator forward rega marang pendapatan|AVGR - Multiplikator Forward P/S|BioSig Technologies, Inc (BSGM) - Rasio rega marang prakiraan pendapatan|Cutera Inc - Rega forward marang dodolan|KNW (Know Labs, Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep inarimedical.com NARI|Multiplikator forward rega marang pendapatan NVRO (Nevro)|RSLS (reshapelifesciences.com) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Silk Road Medical Inc. SILK
